Venus Remedies Ltd (VRL), one of the India’s leading research oriented pharmaceutical firms, has become the first pharma company in the country to have received the prestigious Responsible Export Organization (REO) Certification from the Confederation of Indian Industry (CII). Venus Remedies is among the seven Indian companies across diverse sectors which have been granted the CII’s REO certification in 2022.
The CII REO certification is meant for Indian companies to take up unique practices of involving people and coming up with safety models and initiatives to meet the highest global export standards. The certified companies representing the Indian export market across the globe maintain quality standards keeping pace with the global sustainability and delivery challenges. They are selected only if they are competent enough to keep raising themselves for export standards.
Venus Remedies has been in more than 80 countries across five continents, including the regulated markets like the UK, Italy, Australia, Germany, France, Kazakhstan, South Africa, Mexico, Israel, Hong Kong, Saudi Arabia, Philippines, Thailand and Oman. Their aim is to fulfill their Mission 2025 which is to expand their global presence in at 100 countries. Currently, it has 11 overseas marketing offices, more than 750 market authorizations and over 450 pending authorizations in regulated and emerging markets.